|
1
|
|
|
2
|
- Cancer will become the
leading cause of disease induced death
- Results of more than
- 43,000 patients treated with protons and
- 3,000 patients treated with carbon ions
- show significant advantages for specific tumors
|
|
3
|
|
|
4
|
|
|
5
|
|
|
6
|
|
|
7
|
- Carbon ions produce non-reparable DNA damage
due to double strand breaks (DSB) and clustered damages
- Protons produce mainly single strand breaks
|
|
8
|
- Synchrotron
- 85 - 430 MeV/u for carbon ions
- 50 - 250 MeV for protons
- RF knock-out extraction
- Intensity controlled raster
scanning
- Field size up to 20cm x
20cm
- Penetration depth up to
30cm (water equivalent)
- Workflow- Optimization
- Position verification with x-ray (2D/3D)
- Robotic table
- Oncology Information System (OIS)
- Archiving (PACS)
- Treatment Planning
|
|
9
|
|
|
10
|
- Protons
- In principle all tumors that
are located next to
organs at risk.
- The inverse dose profile
(Bragg Peak) reduces integral dose to non-tumor tissue
- Examples of typical indications:
- Pediatric tumors
- Non malignant brain tumors
- AVM (arterial vein
malformation)
- Head and neck tumors
- Prostate
|
|
11
|
- Carbon ions:
- In principle all tumors that are located next to organs at risk and
where the high LET (linear energy transfer) effect results in an
increased tumor control rate.
These are in general: macroscopic, slowly growing,
radioresistant, hypoxic, and deep seated tumors.
|
|
12
|
|
|
13
|
|
|
14
|
- Carbon treatment of para-aortal Lymphenode (Morbus Hodgkin phase IIB)0
|
|
15
|
- Tumor response after
treatment with 79.2 GyE in 18 fractions (one field per fraction)
|
|
16
|
- Advantages of a “combined” system:
- Protons are clinically
proven (approx. 43,000 patients)
- Carbon ions are currently
used in Chiba, Hyogo, and Darmstadt
for selected
clinical applications (approx. 3,000 patients)
- Additional studies underway
will increase approved applications
|
|
17
|
- 1 x Heavy Ion Gantry
- 2 x Fixed Beam
- 1 x Research Beam
|
|
18
|
- Nov. 2004, Heidelberg has ordered all components related to patient
environment from Siemens:
- Scanning & nozzle
- Robotic patient positioner
- kV imaging (2D and 3D)
- Therapy control system (TCS)
|
|
19
|
|
|
20
|
|
|
21
|
|
|
22
|
- Same look and feel between
different modalities, systems and tasks
- Seamless workflow between
imaging, planning and other
IT systems
- Intuitive and effective
handling of tasks –
easy to use
- Continuous development,
DICOM, industry Standards
|
|
23
|
- * syngo® planning for Particle Therapy is a works-in-progress,
requires FDA premarket clearance, and is not presently available for
commercial distribution in the U.S.
|
|
24
|
- * syngo® planning for Particle Therapy is a works-in-progress,
requires FDA premarket clearance, and is not presently available for
commercial distribution in the U.S.
|
|
25
|
- * syngo® planning for Particle Therapy is a works-in-progress,
requires FDA premarket clearance, and is not presently available for
commercial distribution in the U.S.
|
|
26
|
- GSI – Gesellschaft für Schwerionenforschung
- Society for heavy ion research
(Darmstadt, Germany)
- synchrotron and raster scanning technology
- treatment optimization
- (biological effects
of ions)
- treatment planning software
- knowledge-transfer
- licenses
|
|
27
|
- Siemens and Danfysik Cooperation
- Joint development
- Standardized solution for
Proton and Carbon therapy in one system
- Danfysik is the exclusive
supplier of accelerator systems
for Siemens’ Particle Therapy solutions
- Danfysik’s accelerator
systems include proton and carbon sources,
synchrotron accelerators, and beam delivery systems from
the
synchrotron to the medical treatment rooms
|
|
28
|
- ...a flexible solution based on standardized modules — from one vendor
- Accelerator with beam line
- Scanning and monitoring
system
- Treatment rooms (gantry,
robotic table)
- Patient transport system
- Imaging (diagnostic and
position verification)
- Treatment planning
- IT (oncology information
system, administration,
- archiving, …)
- Project management
- Maintenance solutions
- Technical operating
|
|
29
|
- Total integrated solution with optimized workflow for highest patient
throughput
- Comprehensive service offerings in a long term partnership
- Combined system with Protons and Carbons to make Particle Therapy future
proof
- Technical leadership through top innovations secures your longterm
investments
|
|
30
|
|